Inventor · disambiguated record
Bin Zheng
Also filed as: ZHENG BIN
10 granted patents·4 pending applications·11 citations·filing 2004–2025
80Inventor score
Top patents by PatentIndex Score
14 records- 0178US11613554B2Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 28, 2023·1 cites·17 claims
- 0276US7102001B2Process for preparing pyrrolotriazineBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 5, 2006·9 cites·6 claims
- 0374US12077558B2Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 0472US12269840B2Process for the preparation of a cyclic dinucleotideBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 8, 2025·1 cites·17 claims
- 0565US2024166675A1Novel phosphorous (v)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (v) compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0664US2025197440A1Process for the preparation of a cyclic dinucleotideBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0762US2022177482A1Process for the preparation of n-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0859US12049470B2MK2 inhibitors, the synthesis thereof, and intermediates theretoCELGENE CORP·Filed 2022·Granted Jul 30, 2024·0 cites·20 claims
- 0953US12378246B2Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-oneBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 5, 2025·0 cites·13 claims
- 1050US12492217B2Reagents and their use for modular enantiodivergent synthesis of C—P bondsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 9, 2025·0 cites·19 claims
- 1149US11254679B2Process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 22, 2022·0 cites·1 claims
- 1248US2023416252A1Process toward the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-oneBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1344US10106560B2Process and intermediates for making tubulysin analogsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·0 cites·16 claims
- 1443US9518058B2Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 13, 2016·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Bin Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →